CEACAM5 and cholangiocarcinoma: Although CA19-9 and carcinoembryonic antigen (CEA) are widely used in the diagnosis and disease monitoring of CCA in clinical practice, their sensitivity and specificity are still low, and their role as independent prognostic markers is limited.